Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

4A.01 Should the Lung Microinvasive Adenocarcinoma Be Classified to Stage IA1?

Journal of Thoracic Oncology

English

Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non–Small Cell Lung Cancer Patient

Journal of Thoracic Oncology

English

175P: ALK Positive Lung Cancer: Clinical Profile and Outcomes in a Developing Country

Journal of Thoracic Oncology

English

PUB063 Epidemiologic and Radiomic Analysis of Hyperprogressers of Lung Cancer Patients Treated With Immunotherapy

Journal of Thoracic Oncology

English

An Auristatin Nanoconjugate Targeting CXCR4+ Leukemic Cells Blocks Acute Myeloid Leukemia Dissemination

Journal of Hematology and Oncology

English

Current Findings for Recurring Mutations in Acute Myeloid Leukemia

Journal of Hematology and Oncology

English

P13 Impact of ErbB Mutations on Clinical Outcomes in Afatinib- Or Erlotinib-Treated Patients With SCC of the Lung

Journal of Thoracic Oncology

English

190TiP: ELUXA 1: Phase II Study of BI 1482694 (HM61713) in Patients (Pts) With T790m-Positive Non-Small Cell Lung Cancer (NSCLC) After Treatment With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI)

Journal of Thoracic Oncology

English

Modest Improvements of Survival for Patients With Small Cell Lung Cancer Aged 45 to 59 Years Only, Diagnosed in the Netherlands, 1989 to 2008

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

4A.01 Should the Lung Microinvasive Adenocarcinoma Be Classified to Stage IA1?

Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-Small Cell Lung Cancer

Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non–Small Cell Lung Cancer Patient

175P: ALK Positive Lung Cancer: Clinical Profile and Outcomes in a Developing Country

PUB063 Epidemiologic and Radiomic Analysis of Hyperprogressers of Lung Cancer Patients Treated With Immunotherapy

An Auristatin Nanoconjugate Targeting CXCR4+ Leukemic Cells Blocks Acute Myeloid Leukemia Dissemination

Current Findings for Recurring Mutations in Acute Myeloid Leukemia

P13 Impact of ErbB Mutations on Clinical Outcomes in Afatinib- Or Erlotinib-Treated Patients With SCC of the Lung

190TiP: ELUXA 1: Phase II Study of BI 1482694 (HM61713) in Patients (Pts) With T790m-Positive Non-Small Cell Lung Cancer (NSCLC) After Treatment With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI)

Modest Improvements of Survival for Patients With Small Cell Lung Cancer Aged 45 to 59 Years Only, Diagnosed in the Netherlands, 1989 to 2008